Bruce N. Jacobs - 03 Dec 2021 Form 4 Insider Report for Kymera Therapeutics, Inc. (KYMR)

Role: Chief Financial Officer
Signature: /s/ Bruce N. Jacobs
Issuer symbol: KYMR
Transactions as of: 03 Dec 2021
Net transactions value: -$514,837
Form type: 4
Filing time: 03 Dec 2021, 17:43:26 UTC
Previous filing: 23 Nov 2021
Next filing: 14 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KYMR	Common Stock	Options Exercise	$20,800	+10,000	+57%	$2.08^*	27,514	03 Dec 2021	Direct	F1
transaction	KYMR	Common Stock	Sale	$411,188	-7,713	-28%	$53.31	19,801	03 Dec 2021	Direct	F2, F3
transaction	KYMR	Common Stock	Sale	$107,929	-1,987	-10%	$54.32	17,814	03 Dec 2021	Direct	F2, F4
transaction	KYMR	Common Stock	Sale	$16,520	-300	-1.7%	$55.07	17,514	03 Dec 2021	Direct	F2, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KYMR	Stock Option (Right to Buy)	Options Exercise	$0	-10,000	-5%	$0.000000	189,899	03 Dec 2021	Common Stock	10,000	$2.08	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This number includes 258 shares acquired under the Registrant's employee stock purchase plan on November 30, 2021.
F2	This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 6, 2020.
F3	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.91 to $53.88. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F4	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.92 to $54.74. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F5	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.96 to $55.12. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F6	Twenty-five percent (25%) of the shares underlying this stock option vested on July 1, 2020 and the remaining shares shall vest in equal monthly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.